<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_13(5-6)_185</article-id>
<article-id pub-id-type="doi">10.15836/ccar2018.185</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Mitral regurgitation and other valvular heart diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-6495</contrib-id><name><surname>Pa&#x0161;ali&#x0107;</surname><given-names>Ante</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0555-6863</contrib-id><name><surname>Adrovi&#x0107;</surname><given-names>Leon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3189-8661</contrib-id><name><surname>Fri&#x0161;&#x010D;i&#x0107;</surname><given-names>Tea</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8664-3338</contrib-id><name><surname>Planini&#x0107;</surname><given-names>Zrinka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7904-8899</contrib-id><name><surname>Per&#x010D;i&#x0107;</surname><given-names>Marko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8502-7816</contrib-id><name><surname>Gulin</surname><given-names>Dario</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9701-0253</contrib-id><name><surname>Be&#x0161;i&#x0107;</surname><given-names>Dijana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4488-0559</contrib-id><name><surname>&#x0160;iki&#x0107;</surname><given-names>Jozica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital &#x201C;Sveti Duh&#x201D;</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Zagreb School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Ante Pa&#x0161;ali&#x0107;, Klini&#x010D;ka bolnica &#x201E;Sveti Duh&#x201C;, Sv. Duh 64, HR-10000 Zagreb, Croatia. / Phone: +385-91-3712-083 / E-mail: <email xlink:href="ante.pasalic@outlook.com">ante.pasalic@outlook.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>06</month><year>2018</year></pub-date>
<volume>13</volume>
<issue>5-6</issue>
<fpage>185</fpage>
<lpage>185</lpage>
<history>
<date date-type="received"><day>03</day><month>05</month><year>2018</year></date><date date-type="accepted"><day>10</day><month>05</month><year>2018</year></date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>mitral regurgitation</kwd><kwd>aortic stenosis</kwd><kwd>aortic regurgitation</kwd><kwd>tricuspid regurgitation</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Background</bold>: Mitral regurgitation (MR) represents the second most common valvular heart disease (VHD), with incidence of 24% (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). 10,4% of patients have two and 0.8% three or more concurrent valvular heart disease (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). MR can be isolated or associated with other valvular heart disease, most commonly with tricuspid regurgitation (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). In this article we represent data from our centre.</p>
<p><bold>Patients and Methods:</bold> Retrospective study was conducted to assess the relation between MR with other VHD. A total of 686 patients, with male predominance of 55%, were included in the study. The patients were divided into four groups according to the number of valvular diseases: two, three and four valvular diseases.</p>
<p><bold>Results:</bold> Among the patients with two valvular disease, the most common combination was MR and tricuspid regurgitation (TR) (50.58%). Among the patients with three valvular disease, the combination of MR, aortic regurgitation (AR) and TR was the most common. (17.78%). Finally, four valvular disease was found in 5.98% of patients. In both men and women with two valvular disease, MR and TR, was most frequently found (44.3 and 58.3%) in contrast to MR and AS which was least common combination (16.7 and 26.2%) in both men and women. When it comes to three valvular disease combination of MR, aortic stenosis (AS) and AR or MR, AS and TR was almost the same.</p>
<p><bold>Conclusion</bold>: Our results match the above-mentioned results in general population. MR was most commonly associated with TR. In three valvular disease combinations of MR, AR and TR was the most common in both gender.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andell</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Martinsson</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>C</given-names></name><name><surname>Stagmo</surname><given-names>M</given-names></name><name><surname>Z&#x00F6;ller</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.</article-title> <source>Heart</source>. <year>2017</year> Nov;<volume>103</volume>(<issue>21</issue>):<fpage>1696</fpage>&#x2013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2016-310894</pub-id><pub-id pub-id-type="pmid">28432156</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamorano</surname><given-names>JL</given-names></name><name><surname>Manuel Monteagudo</surname><given-names>J</given-names></name><name><surname>Mesa</surname><given-names>D</given-names></name><name><surname>Gonzalez-Alujas</surname><given-names>T</given-names></name><name><surname>Sitges</surname><given-names>M</given-names></name><name><surname>Carrasco-Chinchilla</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Frequency, Mechanism and Severity of Mitral Regurgitation: Are There any Differences Between Primary and Secondary Mitral Regurgitation?</article-title> <source>J Heart Valve Dis</source>. <year>2016</year> Nov;<volume>25</volume>(<issue>6</issue>):<fpage>724</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">28290172</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
